These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. Rapa I; Saggiorato E; Giachino D; Palestini N; Orlandi F; Papotti M; Volante M J Clin Endocrinol Metab; 2011 Jul; 96(7):2146-53. PubMed ID: 21543427 [TBL] [Abstract][Full Text] [Related]
9. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320 [TBL] [Abstract][Full Text] [Related]
10. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Goutas N; Vlachodimitropoulos D; Bouka M; Lazaris AC; Nasioulas G; Gazouli M Anticancer Res; 2008; 28(1A):305-8. PubMed ID: 18383861 [TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece. Sarika HL; Papathoma A; Garofalaki M; Vasileiou V; Vlassopoulou B; Anastasiou E; Alevizaki M Clin Endocrinol (Oxf); 2012 Dec; 77(6):857-62. PubMed ID: 22676047 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study. Oczko-Wojciechowska M; Pfeifer A; Rusinek D; Pawlaczek A; Zebracka-Gala J; Kowalska M; Kowal M; Swierniak M; Krajewska J; Gawlik T; Chmielik E; Czarniecka A; Szpak-Ulczok S; Jarząb B Endokrynol Pol; 2015; 66(2):121-5. PubMed ID: 25931041 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519 [TBL] [Abstract][Full Text] [Related]
15. Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer. Barollo S; Pezzani R; Cristiani A; Bertazza L; Rubin B; Bulfone A; Pelizzo MR; Torresan F; Mantero F; Pennelli G; Moro S; Mian C Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):546-50. PubMed ID: 23934677 [TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan. Chang CF; Yang WS; Su YN; Wu IL; Chang TC J Formos Med Assoc; 2009 May; 108(5):402-8. PubMed ID: 19443294 [TBL] [Abstract][Full Text] [Related]
17. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type. Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534 [TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations. Chang TC; Wu SL; Hsiao YL Acta Cytol; 2005; 49(5):477-82. PubMed ID: 16334022 [TBL] [Abstract][Full Text] [Related]
20. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]